1. Introduction
===============

The continuously increasing availability of computational resources as well as the development of accurate and efficient quantum chemical approaches have made computational vibrational spectroscopy an indispensable field complementing experimental techniques. Nowadays, almost every quantum chemical software package enables the analysis of second-order properties of the energy (e.g., IR and Raman absorptions, IR intensities, electric dipole polarizabilities, nuclear magnetic resonance chemical shifts, spin-spin coupling constants). Arguably, the prediction of IR and Raman absorptions is among the most important applications considering the prevalence of these technique. While most fundamental IR absorptions can be assigned quite satisfyingly on an empirical basis or via normal coordinate analysis, especially the near-infrared region is cluttered by overtones and combination excitations that are cumbersome to assign.

With regard to computational approaches, the harmonic oscillator approximation (HOA) is the most fundamental technique for obtaining vibrational spectroscopic data. However, due to the rigorous assumption introduced, in that the bond potential exhibits a harmonic shape, significant deviation from experiment is frequently observed. The most simple solution accounting for the lack of anharmonicities is to introduce empirical scaling factors that are multiplied with the harmonically approximated absorptions. Scott and Radom derived scaling factors for a vast number of *ab initio* and semi-empirical methods and a large number of basis sets \[[@B1-molecules-19-21253],[@B2-molecules-19-21253]\]. It has to be stressed, however, that an empirical scaling may not be applied on a system-independent basis, even though the scaling factors have been derived for a rather large set of molecules. Noteworthy, a harmonic bond potential cannot be assumed a proper basis for considerations towards excitations involving more than one quantum of energy.

Especially due to these fundamental deficiencies, further corrective techniques have been developed that account for anharmonicities in an explicit manner. The two most prominent approaches are the vibrational self-consistent field (VSCF) method \[[@B3-molecules-19-21253],[@B4-molecules-19-21253],[@B5-molecules-19-21253],[@B6-molecules-19-21253],[@B7-molecules-19-21253],[@B8-molecules-19-21253]\] and the vibrational second order perturbative ansatz (VPT2) \[[@B9-molecules-19-21253],[@B10-molecules-19-21253]\]. VPT2 is a technique that relies on the computation of higher-order derivatives of the energy. Gaussian \[[@B11-molecules-19-21253]\] is probably the most prominent commercial software package incorporating a VPT2 algorithm which relies on third and semi-diagonal fourth derivatives of the energy with respect to the nuclear coordinates. This method is applied regularly \[[@B12-molecules-19-21253],[@B13-molecules-19-21253]\] but it may only be employed safely to vibrational problems where the harmonic part of the potential is dominant. Moreover, the computationally demanding generation of third and fourth derivatives limits the approach to rather small systems. VSCF on the other hand utilizes a separability ansatz which enables the anharmonicity of each mode to be accounted for by screening the respective potential in a point-wise manner. Mode interactions may be evaluated by computing *d* dimensional grids and the maximum possible dimensionality is determined by the number of vibrational degrees of freedom (*N* ) featured by the molecule under investigation. In a conventional VSCF calculation, each mode's potential is characterized by 16 grid points \[[@B14-molecules-19-21253]\]. In the past, scientific papers have been reported that employed grids of higher (*r* = 32) \[[@B15-molecules-19-21253]\] and lower resolutions (*r* = 8) \[[@B16-molecules-19-21253],[@B17-molecules-19-21253],[@B18-molecules-19-21253]\]. Roy *et al.* \[[@B19-molecules-19-21253]\] recently presented data based on a variety of grid densities ranging from 8 to 16 points. Since they reported overall deviations summed over a set of reference molecules, one could conclude that this rather diverse choice of grid resolutions does not impose a significant error on the wavenumbers. However, to date there still seem to exist ambiguities with regard to a generally applicable grid density that is computationally feasible. Hence, and considering the massive computational effort involved in high resolution VSCF calculations, it seemed promising to conduct a systematic study addressing these issues. 15 reference molecules are investigated in detail and an application to the lowest energy conformer of phosphoserine is presented. At this point it seems worth mentioning that while many quantum chemical software packages such as GAMESS \[[@B20-molecules-19-21253]\], NWChem \[[@B21-molecules-19-21253]\] and MOLPRO \[[@B22-molecules-19-21253]\] incorporate VSCF implementations, GAMESS is the program employed in this work due to the fact that it is freely available and compatible with the most prominent computer operating systems.

2. Methods
==========

In this section, a brief overview describing the procedures underlying a VSCF evaluation is given. Particularities of the involved techniques are presented while reference to the original literature is given for further details.

2.1. Energy Minimization
------------------------

A prerequisite for every computational spectroscopic analysis is a proper structural ensemble. For the majority of cases, the user would want to obtain absorption data corresponding to an equilibrium structure and thus, an energetically favorable reference geometry is required. This implies that at least a local energy minimum (or the global energy minimum) is obtained and this is reflected by a nearly zero gradient of the energy *g*(*q*)∆*q* with respect to the nuclear coordinates *q*. While the program's default criteria suffice for energetical and structural considerations in many cases, a VSCF calculation requires a thoroughly minimized geometry. This condition is realized by setting up rigorous cutoff tolerances for *g*(*q*)∆*q*. We considered a molecular geometry properly minimized when each gradient contribution is smaller than 0.000001 E~*h*~· Bohr^−1^. Every calculation reported herein was performed at the Møller-Plesset level of theory, accounting for electron correlation effects via a perturbative ansatz \[[@B23-molecules-19-21253],[@B24-molecules-19-21253],[@B25-molecules-19-21253]\]. The frozen-core approximation \[[@B26-molecules-19-21253]\] was employed, explicitly correlating all but the core electrons. Dunning's correlation-consistent polarized basis set of triple-*ζ* quality has been utilized since it can be considered a routinely employed set of functions that is known to deliver results of acceptable accuracy \[[@B27-molecules-19-21253]\]. The appropriate point group was imposed onto the molecular geometry where applicable in order to make use of the efficient symmetry optimized SCF algorithm in GAMESS.

2.2. Second Derivatives of the Energy
-------------------------------------

A potential *V*(*q*) may be expressed as a Taylor series $$V(q) = V_{0}(q) + g(q)\Delta q + \frac{1}{2}\Delta q^{T}{\mathbb{H}}\Delta q + \ldots$$ and for the case that the reference geometry resembles an energy minimum and assuming a harmonic potential shape, all but the first and third terms vanish. This simplified approach enables the evaluation of the elements of ℍ~*r,s*~ by analytical or numerical analysis: $${\mathbb{H}}_{r,s} = \frac{\partial^{2}V(q)}{\partial q_{r}\partial q_{s}}$$

A transformation into mass-weighted coordinates and diagonalization of the Hessian matrix ℍ~*r,s*~ yields the eigenvectors corresponding to the normal modes. At this point, computational spectroscopic data at the HOA level is available. It seems worth mentioning that the further description of extended vibrational analysis is based on mass-weighted normal coordinates or other non-redundant coordinates for the sake of clarity, whereas the expansion of the potential energy surfaces was realized in rectilinear coordinates ([Section 3.1](#sec3dot1-molecules-19-21253){ref-type="sec"}). VSCF calculations require a Hessian corresponding to the equilibrium geometry, as will be discussed in the next paragraph. The Hessian matrices in this work have been obtained semi-numerically involving two displacements of ±0.01 Bohr about the reference geometry for each atom.

2.3. The VSCF Routine
---------------------

Even though VSCF accounts for anharmonicities explicitly, it still requires ℍ~*r,s*~ as a reference state. This is owed to the fact, that VSCF assumes a molecule's vibrational wave function Ψ(*Q*~1*,..,N*~) to be separable into single mode wave functions $\psi_{i}^{(n)}$: $$\Psi(Q_{1,\ldots,N}) = {\prod\limits_{i = 1}^{N}\psi_{i}^{(n)}}(Q_{i})$$

While this product ansatz can be implemented rather efficiently, it inherently limits the accuracy of the VSCF technique since it represents decoupled vibrational modes. There are, besides the methods mentioned in [Section 2.4](#sec2dot4-molecules-19-21253){ref-type="sec"}, techniques available which are able to circumvent this limitation \[[@B28-molecules-19-21253],[@B29-molecules-19-21253]\]. Introducing the variational principle \[[@B30-molecules-19-21253],[@B31-molecules-19-21253]\], the single mode VSCF equation \[[@B6-molecules-19-21253],[@B32-molecules-19-21253]\] is formulated as: $$\left\lbrack {- \frac{1}{2}\frac{\partial^{2}}{\partial Q_{i}^{2}} + \overline{V_{i}^{(n)}}(Q_{i})} \right\rbrack\psi_{i}^{(n)}(Q_{i}) = \varepsilon_{i}^{(n)}\psi_{i}^{(n)}(Q_{i})$$ where $\overline{V_{i}^{(n)}}(Q_{i})$ is mode *Q*~*i*~'s effective potential. Equation (4) neglects parts of the full Watson Hamiltonian for non-linear molecules \[[@B33-molecules-19-21253]\] which accounts for *N* vibrational degrees of freedom: $$Ĥ = - \frac{1}{2}{\sum\limits_{i = 1}^{N}{\frac{\partial^{2}}{\partial Q_{i}^{2}} + V(Q_{1,\ldots,N}}}) + \frac{1}{2}{\sum\limits_{\alpha\beta}{\widehat{\pi}}_{\alpha}}\mu_{\alpha\beta}{\widehat{\pi}}_{\beta} - \frac{1}{8}{\sum\limits_{\alpha}\mu_{\alpha\alpha}}$$

The second and third part of the Hamiltonian represent the generalized inverse of the effective moment of inertia *µ*~*αβ*~ and the vibrational angular momentum operator ${\widehat{\pi}}_{\alpha}$. Given that the full Watson Hamiltonian is cumbersome to implement computationally, most implementations resort to neglecting the last two terms of *Ĥ*. The error introduced is small especially for fundamental excitations as has been shown by Bowman *et al.* \[[@B34-molecules-19-21253]\].

The VSCF equations are solved in an iterative manner until self-consistency is achieved. Illustratively, VSCF may be seen as an approach where each vibration is influenced by the mean field of the surrounding modes. However, especially when certain mode interactions exhibit unique properties, this mean field ansatz does no longer properly describe the vibrational problem sufficiently well. A number of post-VSCF techniques accounting for this deficiency have been presented and they are discussed in the subsequent section.

Since the VSCF technique involves a grid-based screening of bond potentials and their interactions, a discussion of the so-called hierarchical expansion is justified. For a system exhibiting *N* normal modes, the VSCF expansion is denoted as: $$V(Q_{1,\ldots,N}) = {\sum\limits_{i = 1}^{N}V_{i}^{diag}}(Q_{i}) + {\sum\limits_{i < j}^{N}V_{i,j}^{pairs}}(Q_{i},Q_{j}) + {\sum\limits_{i < j < k}^{N}V_{i,j,k}^{triples}}(Q_{i},Q_{j},Q_{k}) + \ldots$$

A complete interaction scheme is realized by imposing *N* -dimensionality onto Equation (6) but obviously, such a treatment scales unfavorably with the studied system size. Noteworthy, most applications of VSCF theory truncate the expansion largely by including only ${\sum_{i = 1}^{N}V_{i}^{diag}}(Q_{i})$ and ${\sum_{i < j}^{N}V_{i,j}^{pairs}}(Q_{i},Q_{j})$ contributions \[[@B35-molecules-19-21253],[@B36-molecules-19-21253],[@B37-molecules-19-21253],[@B38-molecules-19-21253]\]. This simplification is valid for a large number of applications and the inclusion of higher-order interaction terms is hardly justifiable for other than the smallest molecules or for cases, where convergence is only achieved when including such terms. Programs such as MULTIMODE \[[@B34-molecules-19-21253],[@B39-molecules-19-21253]\], Molpro \[[@B22-molecules-19-21253]\] and MIDAScpp enable coupling orders of *d* \> 3 yielding IR bands of exceptional accuracy \[[@B7-molecules-19-21253],[@B40-molecules-19-21253]\]. In this article, we confine our discussion to ${\sum_{i = 1}^{N}V_{i}^{diag}}(Q_{i})$ and ${\sum_{i < j}^{N}V_{i,j}^{pairs}}(Q_{i},Q_{j})$ contributions since this study aims at larger molecules where an incorporation of higher coupling terms would be prohibitive. The number of grid points due (*N*~*p*~) is calculated via Equation (7) .

$$N_{p} = r \times N + \frac{N \times (N - 1)}{2} \times r^{2}$$

Assuming *r* = 16 and taking glycine as an example, the pair-wise approximation would require 71,040 points to be computed while a VSCF calculation involving also three-mode interactions already gives rise to 8,361,344 energy evaluations, a nearly 120 fold increase in computational burden. Herein, we will examine the impact of the grid density on the quality of the absorption data by conducting VSCF calculations involving between 6 and 16 grid points per mode. For the displacements underlying the PES scan, a symmetric grid range of \[−4$\omega_{i}^{- 0.5}$, +4$\omega_{i}^{- 0.5}$\], with *ω*~*i*~ being the harmonic frequency of the *i*-th normal mode, was chosen. The grid points within these boundaries have been set-up in an equidistant manner which implies that for even grid densities (*i.e.*, 6, 8, 10, 12, 14 and 16 points), equilibrium is located between the two innermost grid points. For odd grid densities (*i.e.*, 7, 9, 11, 13 and 15 points), equilibrium is described by one distinct grid point. For every resolution *r* \< 16, the grid points are interpolated to the original resolution of *r* = 16 by a polynomial fit.

2.4. Extensions of the VSCF Approach {#sec2dot4-molecules-19-21253}
------------------------------------

As mentioned earlier, the VSCF assumption does not hold for many applications. Therefore, a perturbative approach has been suggested, accounting for the error introduced by the mean-field VSCF ansatz \[[@B15-molecules-19-21253],[@B41-molecules-19-21253],[@B42-molecules-19-21253]\]. A prerequisite is that the difference between the \"true\" energy and the mean-field VSCF energy is small. An expansion known from electronic structure theory \[[@B23-molecules-19-21253]\] is then formulated for the energy and wave function of a state *n* that is truncated at second order: $$E_{n} \approx E_{n}^{0} + \lambda E_{n}^{1} + \lambda^{2}E_{n}^{2}$$ $$\Psi_{n} \approx \Psi_{n}^{0} + \lambda\Psi_{n}^{1} + \lambda^{2}\Psi_{n}^{2}$$ with *H* = $H_{n}^{0}$ + *λ∆V* and an insertion of *E*~*n*~ and Ψ~*n*~ in *H* Ψ~*n*~ = *E*~*n*~Ψ~*n*~, the energy contribution at second order may be formulated as: $$E_{n}^{2} = {\sum\limits_{m \neq n}\frac{\left\langle {\Psi_{n}^{0}\left| {\Delta V} \right|\Psi_{m}^{0}} \right\rangle\left\langle {\Psi_{m}^{0}\left| {\Delta V} \right|\Psi_{n}^{0}} \right\rangle}{E_{n}^{0} - E_{m}^{0}}}$$

Herein, $\Psi_{n}^{0}$ and $\Psi_{m}^{0}$ are the unperturbed vibrational product wave functions and $E_{n}^{0}$ and $E_{m}^{0}$ are the unperturbed VSCF energies. This technique, which is commonly abbreviated as second order perturbation theory augmented (PT2)-VSCF or correlation-corrected (CC)-VSCF, has proven useful for many applications. However, since obtaining correlation-corrected VSCF energies requires significant computational resources, the basic PT2-VSCF approach is limited to small systems. Due to the inherent need for an efficient solution of Equation (10), Gerber's work group developed a solution based on the assumption of orthogonal vibrational single mode wave functions (Equation (3)) which leads to the annihilation of diagonal elements in Equation (10) \[[@B43-molecules-19-21253]\]. Tests involving *Gly*~*n*~ peptides showed that the runtime improvement is greater for larger molecules: for monomeric *Gly*, a speedup factor close to 6 was observed while the correlation-corrected wavenumbers of tetraglycine have been evaluated more than 16 times faster as with the conventional PT2-VSCF ansatz. This acceleration technique, and also the fact that this accelerated PT2-VSCF technique is readily implemented in GAMESS \[[@B20-molecules-19-21253]\], are probably the main reasons for PT2-VSCF being a routinely employed VSCF correction. It has to be stressed, however, that the evaluation of the VSCF equations with its further corrections may not be confused with the preceding and highly demanding evaluation of the potential energy grid (*vide supra*).

Problems may arise when degenerate vibrational states are present. PT2-VSCF can fail here due to a close to zero denominator in Equation (4) which can lead to a largely overestimated perturbative correction. Hence, the degenerate PT2-VSCF method has been developed \[[@B44-molecules-19-21253]\] but to date it has been implemented in GAMESS exclusively for degeneracies arising from fundamental excitations. A more generally available simple solution available in the GAMESS program code is that contributions involving denominators falling below a critical value are excluded from the treatment. Most applications reporting PT2-VSCF derived data rely on this simplification and therefore, we will also confine our calculations to this simplified technique.

Besides perturbation theory augmented VSCF, significant effort is put into post-VSCF techniques involving configuration interaction \[[@B45-molecules-19-21253],[@B46-molecules-19-21253],[@B47-molecules-19-21253],[@B48-molecules-19-21253]\], coupled-cluster \[[@B49-molecules-19-21253],[@B50-molecules-19-21253],[@B51-molecules-19-21253]\] and multi-configurational SCF theory \[[@B52-molecules-19-21253],[@B53-molecules-19-21253]\]. While such methods yield highly accurate data, they are to date only applicable to small vibrational problems with less than 20 atoms.

Due to the popularity of the PT2-VSCF method and the fact that results of good quality at manageable computational cost are available also for larger molecules, all data presented in this paper is corrected exclusively with this perturbative ansatz.

3. Results and Discussion
=========================

The fifteen molecules under investigation gave rise to 176 distinct vibrational degrees of freedom, considering all fundamental stretching, deformation and torsional vibrations. PT2-VSCF can yield questionable or sometimes even divergent results for very low-lying and floppy torsions, which is due to the fact that the PES expansion is conventionally carried out in Cartesian coordinates \[[@B18-molecules-19-21253],[@B19-molecules-19-21253],[@B54-molecules-19-21253]\]. The error induced through an anharmonic correction of such a vibration can exceed the boundaries of accuracy known from the HOA \[[@B54-molecules-19-21253]\]. Hence, the usual procedure is to either treat such vibrations harmonically or to describe the underlying displacements in internal coordinates. A substitution for physically more meaningful internal coordinates was proposed by Njegic and Gordon \[[@B54-molecules-19-21253]\] and could be shown to yield good results for formamide and thioformamide \[[@B55-molecules-19-21253]\] as well as for H~2~O~2~ but by introducing a new expansion technique for the kinetic energy operator \[[@B56-molecules-19-21253]\]. Nonetheless, setting up internal coordinates that properly describe the displacements underlying a VSCF treatment is by no means a trivial task. The GAMESS code is able to identify each normal mode's contributions to particular internal coordinates \[[@B57-molecules-19-21253]\], but the user still has to input a balanced description of each vibrational degree of freedom which can become unmanageably difficult for larger systems. Hence, and especially when large molecules are investigated, the majority of users of VSCF theory resort to a PES expansion in Cartesian coordinates and the contributions of critical torsions are omitted when self-consistency is not achieved.

For glycine (C~2~H~5~NO~2~), three normal modes (*i.e.*, the N-C~*α*~-C~*carb*~-O torsion, the NH~2~ group torsion and *δ*~*C*~*carb*~*O*~2*,oop*~~) had to be excluded from the VSCF treatment since they are known to lead to divergence during a perturbation theory corrected VSCF evaluation \[[@B19-molecules-19-21253]\]. Similarly, for methanol (CH~3~OH) the CO axis torsion has been omitted from the PT2-VSCF treatment due to an inadequate description of this particularly floppy torsional mode within the VSCF framework \[[@B58-molecules-19-21253]\]. Dimethylether also exhibits two floppy torsions involving the C-O axes that have been excluded likewise. For ethane, one normal mode near 290 cm^−1^ \[[@B59-molecules-19-21253],[@B60-molecules-19-21253],[@B61-molecules-19-21253],[@B62-molecules-19-21253]\] was omitted due to its floppy character but the other six missing modes did arise from degenerate states in *ν*~*CH*~3~*,as*~, *δ*~*CH*~3~*,as*~ and *ρ*~*CH*~3~~. Experimentally, these degeneracies cannot be distinguished and since the PT2-VSCF derived values did not exhibit significant numerical discrepancies, each pair of degeneracies is presented as a single mean value for the sake of visibility.

3.1. Performance of the PT2-VSCF Approach {#sec3dot1-molecules-19-21253}
-----------------------------------------

The computationally obtained absorption data are compared to experimental data in [Table 1](#molecules-19-21253-t001){ref-type="table"}. The column headers indicate the employed number of grid points during the VSCF evaluations. As a measure of quality, the mean absolute percentage error *µ* for each molecule and each grid density is calculated according to Equation (11): $$\mu = \frac{100}{N}{\sum\limits_{i = 1}^{N}\left| \frac{ṽ_{Expt}^{i} - ṽ_{VSCF}^{i}}{ṽ_{Expt}^{i}} \right|}$$

The obtained values for *µ* are generally smaller than 2%, which is in good agreement with the recent work by Roy *et al.* \[[@B19-molecules-19-21253]\] who concluded that MP2/cc-pVTZ based PT2-VSCF evaluations exhibit a mean unsigned error of under 2%. MP2 is a topical *ab initio* method that accounts for electron correlation effects to a certain extent and it seems as if for most molecules, this method indeed delivers satisfactory results. Acetonitrile is an exception due to its CN triple bond. However, the particularities of this molecule are discussed elsewhere \[[@B63-molecules-19-21253]\] and it was found that state-of-the-art quantum chemical methods \[[@B64-molecules-19-21253],[@B65-molecules-19-21253],[@B66-molecules-19-21253],[@B67-molecules-19-21253],[@B68-molecules-19-21253],[@B69-molecules-19-21253]\] are required for a proper description of *ν*~*CN*~. Importantly, the more or less ubiquitous stretching motions arising from a methyl group are not described in a reliable manner and this has been recently ascribed to the nature of the MP2 method \[[@B19-molecules-19-21253]\]. Conversely, it was shown that when higher order coupling terms (*i.e.*, ${\sum_{i < j < k}^{N}V_{i,j,k}^{triples}}(Q_{i},Q_{j},Q_{k})$) are included in a DPT2-VSCF \[[@B44-molecules-19-21253]\] treatment, MP2 indeed seems to be a viable *ab initio* method of choice \[[@B63-molecules-19-21253]\]. VSCF data relies on the HOA and hence makes use of the rigid rotor approximation \[[@B70-molecules-19-21253]\] which inherently is co-responsible for discrepancies between experiment and theory. Considering that still a large number of approximations are involved even in state-of-the-art VSCF calculations and their underlying *ab initio* energy evaluations, it must be concluded that computationally derived spectroscopic data are prone to a certain degree of fortuitous error compensation. However, both the data presented by Roy *et al.* \[[@B19-molecules-19-21253]\] and our results indicate that triple-*ζ* based MP2 calculations in a VSCF treatment rather reliably deliver data with no more than 2% of unsigned error.

molecules-19-21253-t001_Table 1

###### 

Computed and experimental absorption data and the calculated values for *µ* in %. n.a. means "not applicable" and n.o. means "not observed".

  H~2~O (C~2*v*~)                             Sym.             6       7       8       9       10       11       12       13       14       15       16       Expt. \[[@B59-molecules-19-21253],[@B71-molecules-19-21253],[@B72-molecules-19-21253]\]
  ------------------------------------------- ---------------- ------- ------- ------- ------- -------- -------- -------- -------- -------- -------- -------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *ν*~*OH*~2~\ ,*as*~                         B~2~             2875    3997    3731    3772    3766     3766     3765     3765     3765     3765     3765     3756
  *ν*~*OH*~2~\ ,*s*~                          A~1~             3041    3785    3657    3691    3684     3683     3683     3682     3682     3682     3682     3652
  *δ*~*OH*~2~~                                A~1~             1216    1688    1570    1590    1586     1586     1586     1586     1586     1586     1586     1595
  *μ*                                                          21.3    5.3     0.8     0.6     0.6      0.6      0.5      0.5      0.5      0.5      0.5      n.a.
  **CO~2~ (D~∞*h*~)**                         **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B73-molecules-19-21253],[@B74-molecules-19-21253]\]
  *ν*~*CO*~2~,*as*~                           $\sum_{g}^{+}$   1791    2547    2359    2391    2386     2386     2385     2385     2385     2385     2385     2349
  *ν*~*CO*~2~,*s*~                            $\sum_{u}^{+}$   993     1408    1255    1319    1316     1315     1315     1315     1315     1315     1315     1285
  *δ*~*CO*~2~~                                ∏~*μ*~           487     699     645     654     653      653      653      653      653      653      653      667
  *δ*~*CO*~2~~                                ∏~*μ*~           487     699     645     654     653      653      653      653      653      653      653      667
  *μ*                                                          25.1    6.9     2.3     2.0     2.0      2.0      2.0      2.0      2.0      2.0      2.0      n.a.
  **CH~2~O (C~2*v*~)**                        **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B75-molecules-19-21253],[@B76-molecules-19-21253],[@B77-molecules-19-21253]\]
  *ν*~*CH*~2~,*as*~                           B~1~             2184    3000    2809    2837    2833     2833     2833     2832     2832     2832     2832     2843
  *ν*~*CH*~2~,*s*~                            A~1~             2250    2905    2801    2823    2818     2818     2818     2817     2817     2817     2817     2782
  *ν~CO~*                                     A~1~             1312    1855    1719    1745    1741     1740     1740     1740     1740     1740     1740     1746
  *δ*~*CH*~2~~                                A~1~             1157    1614    1502    1521    1518     1518     1518     1518     1518     1518     1518     1500
  *ρ*~*CH*~2~~                                B~1~             945     1340    1240    1257    1254     1254     1254     1254     1254     1254     1254     1249
  *ω*~*CH*~2~~                                B~2~             891     1250    1162    1176    1174     1173     1173     1173     1173     1173     1173     1167
  *μ*                                                          23.0    6.4     0.8     0.8     0.7      0.7      0.7      0.7      0.7      0.7      0.7      n.a.
  **C~2~H~2~ (D~∞*h*~)**                      **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B60-molecules-19-21253],[@B78-molecules-19-21253],[@B79-molecules-19-21253],[@B80-molecules-19-21253]\]
  *ν*~*C*~2~*H*~2~,*s*~                       $\sum_{g}^{+}$   2699    3490    3375    3390    3384     3380     3384     3384     3384     3384     3384     3374
  *ν*~*C*~2~*H*~2~,*as*~                      $\sum_{u}^{+}$   2523    3405    3199    3233    3228     3227     3227     3227     3227     3227     3227     3289
  *ν~CC~*                                     $\sum_{g}^{+}$   1469    2046    1912    1937    1932     1932     1932     1932     1932     1932     1932     1974
  *δ*~*C*~2~*H*~2~,*s*~                       ∏~*u*~           557     792     733     746     743      743      743      743      743      743      743      730
  *δ*~*C*~2~*H*~2~,*s*~                       ∏~*u*~           557     792     733     746     743      743      743      743      743      743      743      730
  *δ*~*C*~2~*H*~2~,*as*~                      ∏~*g*~           443     638     589     602     598      598      598      598      598      598      598      612
  *δ*~*C*~2~*H*~2~,*as*~                      ∏~*g*~           443     638     589     602     598      598      598      598      598      598      598      612
  *μ*                                                          24.5    5.2     2.0     1.7     1.8      1.8      1.8      1.8      1.8      1.8      1.8      n.a.
  **HCOOH (C~*s*~)**                          **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B81-molecules-19-21253],[@B82-molecules-19-21253],[@B83-molecules-19-21253],[@B84-molecules-19-21253]\]
  *ν~OH~*                                     A\'              2841    3682    3530    3559    3550     3557     3552     3552     3552     3552     3552     3570
  *ν~CH~*                                     A\'              2246    3134    2959    2983    2978     2977     2977     2977     2977     2977     2977     2943
  *ν~C=O~*                                    A\'              1337    1910    1764    1790    1786     1786     1786     1785     1785     1785     1785     1770
  *δ~CH~*                                     A\'              1043    1480    1367    1384    1381     1381     1381     1381     1381     1381     1381     1387
  *δ~OH~*                                     A\'              982     1367    1265    1280    1277     1277     1277     1277     1277     1277     1277     1387
  *ν~C-O~*                                    A\'              848     1148    1077    1089    1086     1086     1086     1086     1086     1086     1086     1105
  *δ~CH~*                                     A\"              786     1114    1029    1042    1040     1040     1040     1040     1040     1040     1040     1033
  *δ~OH,oop~*                                 A\"              515     631     588     623     609      608      609      609      609      609      609      638
  *δ~OCO~*                                    A\'              469     659     611     619     617      617      617      617      617      617      617      625
  *μ*                                                          22.8    6.0     2.1     1.4     1.7      1.7      1.7      1.7      1.7      1.7      1.7      n.a.
  **CH~4~ (T~*d*~)**                          **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B60-molecules-19-21253],[@B85-molecules-19-21253],[@B86-molecules-19-21253]\]
  *ν*~*CH*~3~,*as*~                           F~2~             2333    3210    3000    3035    3029     3029     3028     3028     3028     3028     3028     3019
  *ν*~*CH*~3~,*as*~                           F~2~             2299    3177    2990    3020    3015     3015     3014     3014     3014     3014     3014     3019
  *ν*~*CH*~3~,*as*~                           F~2~             2330    3209    2999    3033    3028     3027     3027     3027     3027     3027     3027     3019
  *ν*~*CH*~4~,*s*~                            A~1~             2588    2968    2948    2943    2945     2944     2943     2943     2943     2943     2943     2917
  *δ*~*CH*~4~,*as*~                           E                1166    1641    1523    1542    1539     1539     1539     1539     1539     1539     1539     1534
  *δ*~*CH*~4~,*as*~                           E                1166    1641    1523    1542    1539     1539     1539     1539     1539     1539     1539     1534
  *δ*~*CH*~3~,*s*~                            F~2~             993     1390    1293    1309    1306     1306     1306     1306     1306     1306     1306     1306
  *δ*~*CH*~3~,*s*~                            F~2~             992     1390    1293    1309    1306     1306     1306     1306     1306     1306     1306     1306
  *δ*~*CH*~3~,*s*~                            F~2~             993     1390    1294    1309    1307     1307     1307     1306     1306     1306     1306     1306
  *µ*                                                          22.3    5.9     0.9     0.4     0.3      0.3      0.3      0.3      0.3      0.3      0.3      n.a.
  **CH**~3~**Cl (C**~3*v*~**)**               **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B87-molecules-19-21253],[@B88-molecules-19-21253],[@B89-molecules-19-21253],[@B90-molecules-19-21253]\]
  *ν*~*CH*~3~,*as*~                           E                2338    3203    3002    3035    3030     3029     3029     3029     3029     3029     3029     3039
  *ν*~*CH*~3~,*as*~                           E                2306    3192    2974    3019    3016     3015     3015     3015     3015     3015     3014     3039
  *ν*~*CH*~3~,*s*~                            A1               2339    3074    2964    2989    2987     2986     2986     2985     2985     2985     2985     2937
  *δ*~*CH*~3~,*as*~                           E                1106    1555    1445    1463    1460     1460     1460     1460     1460     1460     1460     1452
  *δ*~*CH*~3~,*as*~                           E                1106    1556    1444    1462    1460     1459     1459     1459     1459     1459     1459     1452
  *δ*~*CH*~3~,*s*~                            A1               1036    1464    1357    1375    1372     1372     1371     1371     1371     1371     1371     1355
  *ρ*~*CH*~3~~                                E                773     1099    1017    1031    1028     1028     1028     1028     1028     1028     1028     1017
  *ρ*~*CH*~3~~                                E                776     1099    1020    1033    1031     1031     1031     1031     1031     1031     1031     1017
  *ν~CCl~*                                    A1               585     802     749     760     758      758      758      758      758      758      758      732
  *µ*                                                          23.0    7.0     0.9     1.4     1.2      1.2      1.2      1.2      1.2      1.2      1.2      n.a.
  **CH**~3~**OH (C**~*s*~**)**                **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B60-molecules-19-21253],[@B91-molecules-19-21253],[@B92-molecules-19-21253],[@B93-molecules-19-21253]\]
  ν~OH~                                       A'               2812    3900    3646    3694    3687     3686     3686     3686     3686     3686     3686     3681
  *ν*~*CH*~3~,*as*~                           A'               2301    3198    2984    3035    3030     3029     3028     3028     3028     3028     3028     3000
  *ν*~*CH*~3~,*as*~                           A"               2230    3091    2881    2912    2908     2908     2907     2907     2907     2907     2907     2960
  *ν*~*CH*~3~,*s*~                            A'               2363    2951    2849    2957    2947     2942     2941     2941     2941     2941     2941     2844
  *δ*~*CH*~3~,*as*~                           A'               1130    1587    1475    1493    1490     1490     1490     1490     1490     1490     1490     1477
  *δ*~*CH*~3~,*as*~                           A"               1116    1574    1459    1478    1475     1475     1475     1475     1474     1474     1474     1477
  *δ*~*CH*~3~,*s*~                            A'               1104    1563    1447    1466    1463     1463     1463     1463     1463     1463     1463     1455
  *δ*~*OH*~                                   A'               1020    1458    1342    1362    1359     1359     1358     1358     1358     1358     1358     1345
  *ρ*~*CH*~3~~                                A"               843     1178    1069    1083    1081     1081     1080     1080     1080     1080     1080     1060
  *ν*~*CO*~                                   A'               789     1060    1015    1028    1026     1026     1025     1025     1025     1025     1025     1033
  *µ*                                                          22.9    6.4     0.9     1.3     1.2      1.2      1.2      1.2      1.1      1.1      1.1      n.a.
  **CH**~3~**CN (C**~3*v*~**)**               **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B94-molecules-19-21253],[@B95-molecules-19-21253],[@B96-molecules-19-21253],[@B97-molecules-19-21253],[@B98-molecules-19-21253],[@B99-molecules-19-21253],[@B100-molecules-19-21253]\]
  *ν*~*CH*~3~,*as*~                           E                2281    3153    2940    2972    2967     2967     2967     2966     2966     2966     2966     3009
  *ν*~*CH*~3~,*as*~                           E                2322    3172    2976    2994    2990     2989     2989     2988     2988     2988     2988     3009
  *ν*~*CH*~3~,*s*~                            A~1~             2322    3059    2951    2970    2968     2967     2967     2967     2967     2967     2967     2954
  *ν~CN~*                                     A~1~             1656    2308    2152    2178    2174     2174     2173     2173     2173     2173     2173     2267
  *δ*~*CH*~3~,*as*~                           E                1099    1547    1438    1456    1453     1453     1453     1453     1453     1453     1453     1454
  *δ*~*CH*~3~,*as*~                           E                1099    1550    1437    1456    1453     1453     1453     1453     1453     1453     1453     1454
  *δCH*3 ,*s*                                 A~1~             1047    1487    1378    1397    1394     1394     1394     1393     1393     1393     1393     1389
  *ρ*~*CH*~3~~                                E                788     1121    1037    1052    1049     1049     1049     1049     1049     1049     1049     1041
  *ρ*~*CH*~3~~                                E                789     1122    1038    1053    1050     1050     1050     1050     1050     1050     1050     1041
  *ν~CC~*                                     A~1~             692     983     923     932     930      930      930      930      930      930      930      920
  *δ~CCN~*                                    E                270     395     361     367     366      366      366      366      366      366      366      361
  *δ~CCN~*                                    E                268     395     359     365     364      364      364      364      364      364      364      361
  *µ*                                                          24.4    6.4     1.1     1.1     1.0      1.0      1.0      1.0      1.0      1.0      1.0      n.a.
  C~2~H~4~(D~2*h*~)                           Sym.             6       7       8       9       10       11       12       13       14       15       16       Expt. \[[@B59-molecules-19-21253],[@B60-molecules-19-21253],[@B101-molecules-19-21253],[@B102-molecules-19-21253]\]
  *ν*~*CH*~2~,*as*~                           B~2*u*~          2399    3358    3122    3161    3155     3154     3154     3154     3154     3154     3154     3106
  *ν*~*CH*~2~,*as*~                           B~1*g*~          2379    3328    3095    3133    3127     3126     3126     3126     3126     3126     3126     3103
  *ν*~*CH*~2~,*s*~                            A~*g*~           2297    3152    3047    3055    3052     3051     3051     3051     3051     3051     3051     3026
  *ν*~*CH*~2~,*s*~                            B~3*u*~          2318    3253    3023    3060    3055     3054     3054     3054     3054     3054     3054     2989
  *ν~CC~*                                     A~*g*~           1273    1750    1628    1648    1644     1644     1644     1644     1644     1644     1644     1623
  *δ*~*CH*~2~~                                B~3*u*~          1095    1554    1439    1458    1455     1455     1455     1455     1455     1455     1455     1444
  *δ*~*CH*~2~~                                A~*g*~           1051    1432    1345    1361    1359     1358     1358     1358     1358     1358     1358     1342
  *ρ*~*CH*~2~~                                B~1*g*~          922     1318    1217    1235    1232     1232     1232     1232     1232     1232     1232     1236
  *τ*~*CH*~2~~                                A~*u*~           795     1129    1046    1060    1058     1058     1058     1058     1058     1058     1058     1023
  *ω*~*CH*~2~~                                B~1*u*~          730     1036    960     973     971      971      971      971      971      971      971      949
  *ω*~*CH*~2~~                                B~2*g*~          712     1013    939     951     949      949      949      949      949      949      949      943
  *ρ*~*CH*~2~~                                B~2*u*~          619     893     824     836     834      834      834      834      834      834      834      826
  *µ*                                                          23.4    7.7     0.8     1.5     1.4      1.4      1.3      1.3      1.3      1.3      1.3      n.a.
  **C**~2~**H**~4~**O (C**~2*v*~**)**         **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B60-molecules-19-21253],[@B103-molecules-19-21253],[@B104-molecules-19-21253]\]
  *ν*~*CH*~2~,*as*~                           B~2~             2372    3313    3083    3120    3114     3114     3113     3113     3113     3113     3113     3065
  *ν*~*CH*~2~,*as*~                           A~2~             2361    3296    3067    3104    3098     3098     3097     3097     3097     3097     3097     n.o.
  *ν*~*CH*~2~,*s*~                            A~1~             2378    3097    2939    3047    3064     3058     3057     3056     3056     3056     3056     3018
  *ν*~*CH*~2~,*s*~                            B~1~             2295    3214    2988    3024    3019     3018     3018     3018     3018     3018     3018     3006
  *δ*~*CH*~2~,*s*~                            A~1~             1153    1634    1500    1518    1515     1515     1515     1515     1515     1515     1515     1498
  *δ*~*CH*~2~,*as*~                           B~1~             1121    1590    1472    1492    1489     1489     1489     1489     1489     1489     1489     1472
  *ν~CC~*                                     A~1~             1070    1328    1277    1288    1286     1285     1285     1285     1285     1285     1285     1270
  *ρ*~*CH*~2~~                                A~2~             876     1253    1157    1174    1171     1171     1171     1171     1171     1171     1171     n.o.
  *τ*~*CH*~2~~                                B~2~             871     1244    1149    1166    1163     1163     1163     1163     1163     1163     1163     1142
  *ω*~*CH*~2~~                                B~1~             859     1229    1135    1152    1149     1149     1149     1149     1149     1149     1149     1151
  *ω*~*CH*~2~~                                A~1~             882     1203    1128    1141    1139     1138     1138     1138     1138     1138     1138     1148
  *τ*~*CH*~2~~                                A~2~             783     1117    1032    1047    1044     1044     1044     1044     1044     1044     1044     n.o.
  *ν*~*OC*~2~,*s*~                            A~1~             669     946     877     889     887      887      887      887      887      887      887      877
  *ν*~*OC*~2~,*as*~                           B~1~             624     891     822     833     832      831      831      831      831      831      831      872
  *ρ*~*CH*~2~~                                B~2~             615     885     816     829     827      827      827      827      827      827      827      821
  *µ*                                                          23.3    6.5     1.2     1.4     1.4      1.3      1.3      1.3      1.3      1.3      1.3      n.a.
  **CH**~3~**NH**~2~**(C**~*s*~**)**          **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B105-molecules-19-21253],[@B106-molecules-19-21253],[@B107-molecules-19-21253]\]
  *ν*~*NH*~2~,*as*~                           A"               2629    3517    3318    3348    3343     3343     3343     3343     3343     3343     3343     3411
  *ν*~*NH*~2~,*s*~                            A'               2539    3431    3362    3352    3347     3347     3346     3346     3346     3346     3346     3349
  *ν*~*CH*~3~,*as*~                           A"               2283    3110    2919    2947    2943     2942     2942     2942     2942     2942     2942     2985
  *ν*~*CH*~3~,*as*~                           A'               2283    3079    2907    2960    2957     2956     2956     2956     2955     2955     2955     2963
  *ν*~*CH*~3~,*s*~                            A'               2201    3010    2833    2889    2911     2906     2904     2904     2904     2904     2904     2816
  *δ*~*NH*~2~~                                A'               1223    1733    1596    1610    1608     1608     1608     1608     1608     1608     1608     1642
  *δ*~*CH*~3~,*as*~                           A"               1132    1601    1483    1503    1500     1494     1500     1500     1500     1500     1500     1481
  *δ*~*CH*~3~,*as*~                           A'               1119    1581    1467    1487    1484     1483     1483     1483     1483     1483     1483     1463
  *δ*~*CH*~3~,*s*~                            A'               1083    1534    1421    1440    1437     1437     1436     1436     1436     1436     1436     1450
  *ρ*~*CH*~3~~                                A"               998     1420    1314    1331    1328     1328     1328     1328     1328     1328     1328     n.o.
  *ρ*~*CH*~3~~                                A'               891     1237    1152    1169    1167     1167     1167     1167     1167     1167     1167     1144
  *ν~CN~*                                     A'               845     1109    1045    1059    1057     1057     1057     1057     1057     1057     1057     1050
  *τ*~*NH*~2~~                                A"               725     1052    967     981     979      979      979      979      979      979      979      n.o.
  *ω*~*NH*~2~~                                A'               637     909     840     852     851      850      850      850      850      850      850      816
  *CN axis torsion*                           A"               245     316     345     337     307      313      316      313      313      314      314      304
  *µ*                                                          22.8    5.9     2.4     2.3     1.6      1.7      1.8      1.7      1.7      1.7      1.7      n.a.
  **C~2~H~6~(D~3*d*~)**                       **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B60-molecules-19-21253],[@B61-molecules-19-21253],[@B62-molecules-19-21253],[@B108-molecules-19-21253],[@B109-molecules-19-21253]\]
  *ν*~*CH*~3~,*as*~                           E~*u*~           2309    3221    2999    3037    3031     3030     3030     3030     3030     3030     3030     2985
  *ν*~*CH*~3~,*as*~                           E~*g*~           2290    3185    2967    3011    3007     3006     3006     3006     3006     3006     3006     2969
  *ν*~*CH*~3~,*s*~                            A~1*g*~          2470    3006    2950    2981    3004     2996     2995     2995     2994     2994     2994     2954
  *ν*~*CH*~3~,*s*~                            A~2*u*~          2250    3172    2943    2982    2976     2975     2975     2975     2975     2975     2975     2896
  *δ*~*CH*~3~,*as*~                           E~*g*~           1123    1596    1474    1494    1491     1491     1491     1491     1491     1491     1491     1468
  *δ*~*CH*~3~,*as*~                           E~*u*~           1123    1593    1475    1496    1493     1493     1492     1492     1492     1492     1492     1469
  *δ*~*CH*~3~,*s*~                            A~1*g*~          1059    1501    1393    1411    1408     1408     1408     1408     1408     1408     1408     1388
  *δ*~*CH*~3~,*s*~                            A~2*u*~          1042    1482    1372    1392    1389     1389     1388     1388     1388     1388     1388     1379
  *ρ*~*CH*~3~~                                E~*g*~           909     1294    1197    1215    1212     1212     1212     1212     1212     1212     1212     1190
  *ν~CC~*                                     A~1*g*~          818     1051    1003    1010    1008     1008     1008     1008     1008     1008     1008     995
  *ρ*~*CH*~3~~                                E~*u*~           620     899     828     842     839      839      839      839      839      839      839      822
  *µ*                                                          22.3    7.5     0.6     1.7     1.6      1.6      1.6      1.6      1.6      1.6      1.6      n.a.
  **CH**~3~**OCH**~3~**(C**~2*v*~**)**        **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B59-molecules-19-21253],[@B60-molecules-19-21253],[@B110-molecules-19-21253],[@B111-molecules-19-21253]\]
  *ν*~*CH*~3~,*as*~                           A~1~             2339    3142    2945    3016    3013     3012     3012     3011     3011     3011     3011     2996
  *ν*~*CH*~3~,*as*~                           B~1~             2313    3145    2949    2976    2976     2976     2975     2975     2975     2975     2975     2996
  *ν*~*CH*~3~,*as*~                           A~2~             2242    3126    2906    2942    2936     2936     2936     2936     2936     2936     2935     2952
  *ν*~*CH*~3~,*as*~                           B~2~             2236    3117    2899    2934    2928     2928     2928     2928     2928     2928     2928     2925
  *ν*~*CH*~3~,*s*~                            A~1~             2206    2949    2825    2869    2852     2856     2855     2855     2855     2855     2854     2817
  *ν*~*CH*~3~,*s*~                            B~1~             2200    3080    2861    2897    2891     2891     2891     2891     2891     2891     2891     2817
  *δ*~*CH*~3~,*as*~                           A~1~             1142    1597    1488    1506    1503     1503     1503     1503     1503     1503     1503     1464
  *δ*~*CH*~3~,*as*~                           B~2~             1122    1587    1475    1494    1492     1491     1491     1491     1491     1491     1491     1464
  *δ*~*CH*~3~,*as*~                           B~1~             1118    1589    1475    1494    1491     1491     1491     1491     1491     1491     1491     1464
  *δ*~*CH*~3~,*as*~                           A~2~             1111    1579    1466    1485    1482     1482     1482     1482     1482     1482     1482     1464
  *δ*~*CH*~3~,*s*~                            A~1~             1114    1574    1460    1479    1476     1475     1475     1475     1475     1475     1475     1452
  *δ*~*CH*~3~,s~                              B~1~             1082    1541    1426    1445    1442     1442     1442     1442     1442     1442     1442     1452
  *ρ*~*CH*~3~~                                A~1~             944     1349    1248    1265    1263     1262     1262     1262     1262     1262     1262     1244
  *ρ*~*CH*~3~~                                B~1~             897     1275    1181    1197    1194     1194     1194     1194     1194     1194     1194     1227
  *ρ*~*CH*~3~~                                B~2~             893     1273    1180    1194    1195     1190     1189     1188     1188     1188     1188     1179
  *ρ*~*CH*~3~~                                A~2~             871     1245    1153    1168    1166     1166     1166     1166     1166     1166     1166     1150
  *ν*~*C*~2~*O,as*~                           B~1~             839     1207    1113    1129    1127     1127     1126     1126     1126     1126     1126     1102
  *ν*~*C*~2~*O,s*~                            A~1~             780     988     941     950     949      949      949      948      948      948      948      928
  *δ*~*C*~2~*O*~                              A~1~             333     452     423     429     428      428      428      428      428      428      428      418
  *µ*                                                          23.0    7.2     1.1     1.7     1.6      1.5      1.5      1.5      1.5      1.5      1.5      n.a.
  **C**~2~**H**~5~**NO**~2~**(C**~*s*~**)**   **Sym.**         **6**   **7**   **8**   **9**   **10**   **11**   **12**   **13**   **14**   **15**   **16**   **Expt.** \[[@B112-molecules-19-21253],[@B113-molecules-19-21253]\]
  *ν~OH~*                                     A'               2773    3737    3524    3557    3552     3551     3551     3550     3550     3550     3550     3560
  *ν*~*NH*~2~,*as*~                           A"               2609    3556    3337    3370    3365     3364     3364     3364     3364     3364     3364     3410
  *ν*~*NH*~2~,*s*~                            A'               2629    3480    3346    3357    3352     3351     3351     3351     3351     3350     3350     n.o.
  *ν*~*CH*~2~,*as*~                           A"               2268    3101    2907    2937    2932     2932     2932     2931     2931     2931     2931     n.o.
  *ν*~*CH*~2~,*s*~                            A'               2265    3059    2982    2957    2953     2952     2952     2952     2952     2952     2952     2958
  *ν~C=O~*                                    A'               1346    1921    1777    1802    1798     1798     1798     1798     1798     1798     1798     1779
  *δ*~*NH*~2~~                                A'               1228    1750    1602    1620    1617     1617     1617     1617     1617     1617     1617     1630
  *δ*~*CH*~2~~                                A'               1085    1532    1421    1440    1437     1437     1437     1437     1437     1437     1437     1429
  *ν*~*C−O*~                                  A'               1043    1482    1372    1391    1388     1388     1388     1387     1387     1387     1387     1373
  *τ*~*CH*~2~,*NH*~2~~                        A"               1030    1466    1355    1374    1371     1371     1371     1371     1370     1370     1370     n.o.
  *ω*~*CH*~2~~                                A'               968     1382    1275    1293    1290     1290     1290     1290     1290     1290     1290     n.o.
  *δ~CCN,oop~*                                A"               881     1262    1164    1181    1178     1178     1178     1178     1178     1178     1178     n.o.
  *ν~CN~*                                     A'               905     1245    1156    1172    1169     1169     1169     1169     1169     1169     1169     1136
  *δ*~*CO*~2~~                                A'               832     1186    1097    1113    1110     1110     1110     1110     1110     1110     1110     1101
  *δ*~*CNH*~2~~                               A'               716     1002    922     938     935      935      934      934      934      934      934      907
  *δ*~*C=O,oop*~                              A"               685     990     910     924     922      922      922      922      922      922      922      883
  *ν*~*C\ −C*~                                A'               658     863     815     823     822      822      822      822      822      822      822      801
  *δ*~*C=O,ip*~                               A'               486     678     629     637     636      636      636      636      636      636      636      619
  *C-O axis torsion*                          A"               369     529     475     485     483      483      483      483      483      483      483      500
  *O-C*~2~*N axis shear*                      A'               365     495     461     467     466      466      466      466      466      466      466      463
  *O=C*~2~*N axis shear*                      A'               194     286     262     266     266      266      266      266      266      266      266      n.o.
  *µ*                                                          22.8    7.5     1.5     1.8     1.7      1.7      1.7      1.7      1.7      1.7      1.7      n.a.

3.2. Performance at Reduced Grid Densities
------------------------------------------

As a VSCF evaluation with 16 grid points per mode is computationally highly demanding, a reduction of the grid density is desirable. From the data in [Table 1](#molecules-19-21253-t001){ref-type="table"} it becomes evident that for most cases, a reduction to 10 grid points yields identical results as the corresponding calculation with 16 grid points, indicating that the computational demand in a VSCF treatment of ${\sum_{i = 1}^{N}V_{i}^{diag}}(Q_{i})$ and ${\sum_{i < j}^{N}V_{i,j}^{pairs}}(Q_{i},Q_{j})$ contributions can be reduced safely by more than 50%. It has to be kept in mind, however, that for every set of reduced densities, the grid is interpolated to the original resolution and the displacement boundaries are not affected by the reduction. Hence, as long as the points on the potential energy surface are chosen properly, the accuracy of the VSCF results is not affected. Noteworthy, the default routine in GAMESS chooses the displacement boundaries in dependence to the underlying normal mode's wavenumber but the user is nonetheless able to alter these settings if desired.

molecules-19-21253-t002_Table 2

###### 

Obtained values for *µ* in %, their arithmetic means and the corresponding *t*-values according to Equation (12). n.a. means "not applicable".

  Number of Grid Points                                                                                
  --------------------------- -------- ------- ------ ------ ------ ------ ------ ------ ------ ------ ------
  **H~2~O**                   21.3     5.3     0.8    0.6    0.6    0.6    0.5    0.5    0.5    0.5    0.5
  **CO~2~**                   25.1     6.9     2.3    2.0    2.0    2.0    2.0    2.0    2.0    2.0    2.0
  **CH~2~O**                  23.0     6.4     0.8    0.8    0.7    0.7    0.7    0.7    0.7    0.7    0.7
  **C~2~H~2~**                24.5     5.2     2.0    1.7    1.8    1.8    1.8    1.8    1.8    1.8    1.8
  **HCOOH**                   22.8     6.0     2.1    1.4    1.7    1.7    1.7    1.7    1.7    1.7    1.7
  **CH**~4~                   22.3     5.9     0.9    0.4    0.3    0.3    0.3    0.3    0.3    0.3    0.3
  **CH**~3~**Cl**             23.0     7.0     0.9    1.4    1.2    1.2    1.2    1.2    1.2    1.2    1.2
  **CH**~3~**OH**             22.9     6.4     0.9    1.3    1.2    1.2    1.2    1.2    1.1    1.1    1.1
  **CH**~3~**CN**             24.4     6.4     1.1    1.1    1.0    1.0    1.0    1.0    1.0    1.0    1.0
  **C**~2~**H**~4~            23.4     7.7     0.8    1.5    1.4    1.4    1.3    1.3    1.3    1.3    1.3
  **C**~2~**H**~4~**O**       23.3     6.5     1.2    1.4    1.4    1.3    1.3    1.3    1.3    1.3    1.3
  **CH**~3~**NH**~2~          22.8     5.9     2.4    2.3    1.6    1.7    1.8    1.8    1.7    1.7    1.7
  **C**~2~**H**~6~            22.3     7.5     0.6    1.7    1.6    1.6    1.6    1.6    1.6    1.6    1.6
  **CH**~3~**OCH**~3~         23.0     7.2     1.1    1.7    1.6    1.5    1.5    1.5    1.5    1.5    1.5
  **C**~2~**H**~5~**NO**~2~   22.8     7.5     1.5    1.8    1.7    1.7    1.7    1.7    1.7    1.7    1.7
  **Mean** *µ*                23.1     6.5     1.3    1.4    1.3    1.3    1.3    1.3    1.3    1.3    1.3
  ***t*-Value**               102.96   25.59   0.09   2.43   0.81   0.78   1.71   1.34   0.66   2.39   n.a.

Reviewing the values for *µ* in [Table 2](#molecules-19-21253-t002){ref-type="table"} permits the conclusion that major errors are starting to appear at grid densities \<8 points. The GAMESS manual states that the VSCF code is "thought to give accuracy to 50 cm^−1^ for the larger fundamentals" when MP2 with a triple-*ζ* basis set is employed and hence, the boundaries of accuracy are wider than the error inflicted by a reduction of the grid density to 8 points. In order to provide statistical evidence as to what extent a reduction of the grid density is viable, paired t-tests \[[@B114-molecules-19-21253]\] of the obtained values for *µ* have been conducted with the following equation: $$t = \frac{\left| {\sum\limits_{i = 1}^{\chi}\frac{\mu_{ref} - \mu_{calc}}{\chi}} \right|}{s_{d}} \times \sqrt{\chi}$$

In Equation (12), *µ*~*ref*~ is the reference value at a grid density of 16 points. *µ*~*calc*~ is the mean absolute percentage deviation at the examined grid density. *χ* is the number of investigated molecules and the *t*-value is calculated with *s*~*d*~ as the corrected sample standard deviation of the respective grid density. For a two-tailed problem, critical values for *t* can be specified according to [Table 3](#molecules-19-21253-t003){ref-type="table"}.

molecules-19-21253-t003_Table 3

###### 

Critical boundaries according to Student's t-distribution for a two-tailed problem.

  *t*-Value            Difference
  -------------------- --------------------
  t ≤ 2.145            Insignificant
  2.145 \< t ≤ 2.977   Probable
  2.977 \< t ≤ 4.140   Significant
  4.140 \< t           Highly significant

Except for the data obtained at grid densities of 6 and 7 points, no significant deviations from the reference data are observed, indicating that even a reduction to 8 grid points is a very viable option. The computational effort involved in a pair-approximated VSCF evaluation (Equation (7)) may thus be reduced by a factor of nearly 4. It has to be stressed, however, that the obtained *t*-value for *r* = 8 (*i.e.*, 0.09) may not be confused as to indicate the objectively best agreement with the reference values since the statistical analysis is based on unsigned error values. Moreover, the anharmonic correction seems to be slightly over-estimated at *r* = 8, yielding more red-shifted absorptions, as can be learned from [Table 1](#molecules-19-21253-t001){ref-type="table"}. This over-correction is responsible for a slightly improved agreement with experiment for most of the molecules, especially since it is known that MP2 tendentially yields blue-shifted IR absorptions \[[@B19-molecules-19-21253]\]. Overall, it may be concluded that VSCF treatments involving at least 8 grid points reproduce the experimental values within the same boundaries of accuracy as the reference values with a mean absolute percentage deviation from experiment of \~1.3% ([Table 2](#molecules-19-21253-t002){ref-type="table"}).

In their recent paper, Roy *et al.*, reported that soft and semi-rigid molecules have to be treated at higher grid densities than rigid molecules and they mention ethylene oxide as a particular example where the VSCF equations converge at no less than 12 grid points. Our results contradict this statement since our VSCF calculations of ethylene oxide did indeed converge for grid densities ≥6 points and a density of 8 points yielded the same quality of results as observed for the other molecules. Given the fact that the identical code, the same *ab initio* method and the same basis set were employed, this outcome is rather puzzling. This disagreement may be ascribed to the use of symmetry during our VSCF calculations and the underlying reference geometries having been minimized to the most stringent criterion available. Overall, none of our VSCF evaluations exhibited convergence problems apart from the few excluded torsional degrees of freedom that have been mentioned earlier.

3.3. Application to Deprotonated Phosphoserine
----------------------------------------------

Phosphorylation of proteins is considered a major signal transduction mechanism, mainly occurring at the OH terminus of the amino acids serine, threonine and tyrosine. As a major constituent of biofluids, phosphoserine was subject of a gas-chromatographic investigation of human urine samples \[[@B115-molecules-19-21253]\]. In autopsied Alzheimer's disease brain tissue, [l]{.smallcaps}-phosphoserine was found in elevated concentrations \[[@B116-molecules-19-21253]\] and only very recently, plasma phosphoserine levels were found to be upregulated in sepsis patients \[[@B117-molecules-19-21253]\]. Deprotonated phosphoserine, abbreviated as \[pSer-H\]^−^, was investigated via infrared multiple photon dissociation (IRMPD) spectroscopy and hence, experimental data of a few major gas phase IR absorptions of the molecule is available \[[@B118-molecules-19-21253]\]. The authors identified the lowest energy conformer of \[pSer-H\]^−^ as the one exhibiting hydrogen bonds between the carboxylic OH and the phosphate O as well as between the phosphate OH and the amino N. This conformer was chosen as a benchmark for the 8 point VSCF analysis due to the fact that it represents rigid and weak structural motifs likewise. [Figure 1](#molecules-19-21253-f001){ref-type="fig"} shows the minimum geometry obtained at the MP2/cc-pVTZ level of theory which served as a reference state for the VSCF evaluation. [Table 4](#molecules-19-21253-t004){ref-type="table"} lists the PT2-VSCF computed absorptions of \[pSer-H\]^−^, the respective intensities and the available experimental data \[[@B118-molecules-19-21253]\]. Due to the cage-like structure, many normal modes couple among each other and hence, especially lower vibrations cannot be ascribed to distinct normal modes. In such cases, the main vibrational contributions are given in [Table 4](#molecules-19-21253-t004){ref-type="table"}. For illustrative purposes, the calculated IR spectrum of \[pSer-H\]^−^ is shown in [Figure 2](#molecules-19-21253-f002){ref-type="fig"}. The intensities have been computed using harmonic dipole derivatives at the MP2/cc-pVTZ level of theory and band broadening was introduced via a Lorentzian function using a band width at half height of 20 cm^−1^.

![The lowest energy conformer of \[pSer-H\]^−^ exhibits a hydrogen bond between the carboxylic OH and the phosphate O and between the phosphate OH and the amino N.](molecules-19-21253-g001){#molecules-19-21253-f001}

![The computed IR spectrum of \[pSer-H\]^−^. For band assignments, refer to [Table 4](#molecules-19-21253-t004){ref-type="table"}.](molecules-19-21253-g002){#molecules-19-21253-f002}
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###### 

The main absorptions of \[pSer-H\]^−^ and the experimentally obtained \[[@B118-molecules-19-21253]\] values.

  Band Number   PT2-VSCF (cm^−1^)   Intensity (km mol^−1^)   IRMPD (cm^−1^) \[[@B118-molecules-19-21253]\]   Main Contributions
  ------------- ------------------- ------------------------ ----------------------------------------------- ---------------------------------------------------------------------------------------------------------
  1             3430                225                      n.o.                                            *ν*~*OH*~
  2             3346                11                       n.o.                                            *ν*~*NH*~2~*,as*~
  3             3139                125                      n.o.                                            *ν*~*NH*~2~*,s*~
  4             2945                21                       n.o.                                            *ν*~*C*~*α*~*H*~
  5             2915                47                       n.o.                                            *ν*~*C*~*β*~*H*~2~*,s*~
  6             2888                35                       n.o.                                            *ν*~*C*~*β*~*H*~2~*,as*~
  7             1734                359                      1728                                            *ν*~*C*~*carb*~~ =*O*
  8             1565                39                       1610                                            *δ*~*NH*~2~~
  9             1512                244                      1461                                            *δ*~*C*~*carb*~*OH,ip*~
                1449                1                        1419                                            *δ*~*C*~*β*~*H*~2~~
                1380                4                        n.o.                                            *τ*~*NH*~2~~ and *δ*~*NC*~*α*~*H*~
                1371                9                        n.o.                                            *ω*~*C*~*β*~*H*~2~~
                1337                68                       n.o.                                            *ν*~*C*~*carb*~*−O*~ and *τ*~*C*~*β*~*H*~2~~
  10            1315                484                      1291                                            *ν*~*P*~ =*O*
                1292                21                       n.o.                                            *ω*~*C*~*β*~*H*~2~~ and *δ*~*C*~*carb*~*C*~*α*~*H*~ and *ν*~*C*~*carb*~*−O*~
  11            1251                24                       n.o.                                            *ν*~*C*~*α*~\ −\ *C*~*β*~~ and *δ*~*C*~*β*~*C*~*α*~*H*~ and *ν*~*C*~*α*~*−N*~ and *τ*~*NH*~2~~
                1230                6                        n.o.                                            *ν*~*C*~*carb*~*C*~*α*~~ and *δ*~*C*~*carb*~*C*~*α*~*H*~ and *τ*~*NH*~2~~
  12            1176                60                       n.o.                                            *δ*~*C*~*carb*~*OH,oop*~
  13            1157                51                       n.o.                                            *ν*~*C*~*β*~*O*~
  14            1113                99                       1108                                            *δ*~*POH*~
  15            1084                74                       n.o.                                            *ν*~*NC*~*α*~*C*~*carb*~*,as*~ and *ν*~*C*~*β*~*O*~
  16            1060                141                      1052                                            *ω*~*NH*~2~~
  17            1017                121                      1028                                            *ν*~*P\ −\ O*~*H\ −bonded*~~
  18            957                 113                      n.o.                                            *ν*~*NC*~*α*~*C*~*β*~*,as*~
  19            915                 17                       n.o.                                            *ν*~*NC*~*α*~*C*~*β*~*,s*~ and *ν*~*NC*~*α*~*C*~*carb*~*,as*~ and *ν*~*C*~*carb*~*C*~*α*~*C*~*β*~*,as*~
  20            830                 98                       836                                             *ν*~*P\ −OH*~
                823                 24                       812                                             *δ*~*C*~*carb*~*C*~*α*~*C*~*β*~~ and *δ*~*C*~*carb*~*O*~2~*,oop*~
                787                 7                        n.o.                                            *δ*~*C*~*carb*~*O*~2~~ and *δ*~*C*~*carb*~*C*~*α*~*C*~*β*~~
  21            736                 120                      738                                             *ν*~*P\ −OC*~*β*~~ and *δ*~*C*~*carb*~*O*~2~~
  22            692                 39                       n.o.                                            *δ*~*C*~*α*~*NC*~*β*~*C*~*carb*~*,umbrella*~ and *ν*~*P\ −\ OC*~*beta*~~
                513                 41                       n.o.                                            *δ*~*POH,oop*~

Considering the 11 available experimental values, *µ* was computed for the corresponding VSCF data as 1.38%. Since we did calculate the IR absorptions of \[pSer-H\]^−^ exclusively using 8 grid points per mode, no definitive conclusion can be drawn whether higher grid densities would enable an improved accuracy for this larger molecule. A re-evaluation of the potential energy surface at grid densities up to 16 points would be unmanageably expensive but nonetheless, the data presented fits well into the error boundaries as observed for the 15 molecules discussed earlier.

The band assignment in [Table 4](#molecules-19-21253-t004){ref-type="table"} clearly shows that empirical considerations are only applicable to the large fundamentals. For a proper description of low lying vibrations that are determined by a number of torsions, computational approaches are an important option aiding the spectroscopist. In their experimental work, Scuderi *et al.*, have employed computational techniques during their band assignment of \[pSer-H\]^−^ as well, but they resorted to scaled HOA absorption data at the B3LYP/6-311+G(d,p) level of theory.

4. Conclusions
==============

VSCF theory has grown an important field in computational spectroscopy and this is owed to the increasingly available computational resources and to efficient and easily applicable algorithms. With this systematic study it has been demonstrated that a largely reduced grid density in a VSCF evaluation does not only spare considerable resources but also does not significantly affect the resulting absorption data. It was found that the convergence of VSCF equations is not impaired by such a reduced-effort technique even when highly problematic densities of \<8 grid points are employed. While further investigations are required with regard to the role of symmetry in a VSCF treatment, it was found that reduced grid densities may be safely applied to a wide set of molecular entities. Application to \[pSer-H\]^−^ showed that a 8 point VSCF calculation yields accurate data for a molecule exhibiting weak interactions. The routine presented herein should, in conjunction with other recent developments \[[@B35-molecules-19-21253]\], prove valuable for larger molecules relevant to life sciences where a conventional VSCF treatment with 16 grid points per mode is not feasible.
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